Discovery of HN37 as a Potent and Chemically Stable Antiepileptic Drug Candidate
Authors:
- 30 April 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 64 (9) , 5816-5837
Abstract
We previously reported that P-retigabine (P-RTG), a retigabine (RTG) analogue bearing a propargyl group at the nitrogen atom in the linker of RTG, displayed moderate anticonvulsant efficacy. Recently, our further efforts led to the discovery of HN37 (pynegabine), which demonstrated satisfactory chemical stability upon deleting the ortho liable −NH2 group and installing two adjacent methyl groups to the carbamate motif. HN37 exhibited enhanced activation potency toward neuronal Kv7 channels and high in vivo efficacy in a range of pre-clinical seizure models, including the maximal electroshock test and a 6 Hz model of pharmacoresistant limbic seizures. With its improved chemical stability, strong efficacy, and better safety margin, HN37 has progressed to clinical trial in China for epilepsy treatment.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2009CB940900, 2013CB910604, 2013ZX09103-001-016)
- Science and Technology Commission of Shanghai Municipality (11431921102, 19431906000)
- National Natural Science Foundation of China (30725049, 81021062, 81072652, 81825021)
- Chinese Academy of Sciences (CASIMM0120151001, XDA01040301, XDA12040211)
This publication has 55 references indexed in Scilit:
- The gating charge pathway of an epilepsy-associated potassium channel accommodates chemical ligandsCell Research, 2013
- Phosphatidylinositol 4,5-bisphosphate alters pharmacological selectivity for epilepsy-causing KCNQ potassium channelsProceedings of the National Academy of Sciences, 2013
- Clinical utility, safety, and tolerability of ezogabine (retigabine) in the treatment of epilepsyDrug, Healthcare and Patient Safety, 2012
- Bandrowski’s Base Revisited: Toward a Unprecedented Class of Quinonediimines or New Two-Way Chromophoric Molecular SwitchesThe Journal of Organic Chemistry, 2010
- Investigation of the in Vitro Metabolism of the Analgesic FlupirtineDrug Metabolism and Disposition, 2009
- Kv7 (KCNQ) Channel Modulators and Neuropathic PainJournal of Medicinal Chemistry, 2007
- Three Mechanisms Underlie KCNQ2/3 Heteromeric Potassium M-Channel PotentiationJournal of Neuroscience, 2004
- The Conformation of Some Disubstituted AnilidesJournal of Chemical Research, 2004
- The crystal structure of lidocaine hydrochloride monohydrateActa Crystallographica Section B: Structural Science, Crystal Engineering and Materials, 1972
- Laboratory Evaluation of Antiepileptic DrugsEpilepsia, 1969